Edition:
United States

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

9.19USD
21 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$9.19
Open
$9.19
Day's High
$9.33
Day's Low
$9.15
Volume
124,280
Avg. Vol
32,965
52-wk High
$17.76
52-wk Low
$7.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.17 -0.363
Mar '18 0.19 -0.373
FY 2017 Dec '17 0.00 -0.627
Sep '17 0.00 -0.302
Jun '17 0.00 -0.195
Mar '17 0.00 -0.315
FY 2016 Dec '16 0.00 -0.171
Sep '16 0.00 -0.122
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.45 32.71
P/E High - Last 5 Yrs. -- 279.26 47.27
P/E Low - Last 5 Yrs. -- 98.01 24.80
Beta -- 0.61 0.87
Price to Sales (TTM) 509.71 110.80 6.42
Price to Book (MRQ) 3.76 12.48 3.91
Price to Tangible Book (MRQ) 3.77 18.85 5.97
Price to Cash Flow (TTM) -- 62.31 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 179.03 8.45
Sales (TTM) vs TTM 1 Yr. Ago -- 93.99 6.71
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -86.08 283.55 25.51
EPS (TTM) vs TTM 1 Yr. Ago -107.60 -- --
EPS - 5 Yr. Growth Rate -- 23.64 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.63 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.20
Current Ratio (MRQ) 12.69 5.47 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.21
Total Debt to Equity (MRQ) 0.00 18.60 14.02
Interest Coverage (TTM) -- -198.17 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.73
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -8,219.76 -- --
EBITD - 5 Yr. Avg -- -176.77 15.89
Operating Margin (TTM) -8,388.38 -608.74 3.72
Operating Margin - 5 Yr. Avg. -- -190.37 11.01
Pre-Tax Margin (TTM) -8,341.26 -605.96 4.04
Pre-Tax Margin - 5 Yr. Avg. -- -192.95 11.19
Net Profit Margin (TTM) -8,341.26 -600.63 0.77
Net Profit Margin - 5 Yr. Avg. -- -190.59 7.53
Effective Tax Rate (TTM) -- 11.58 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.15 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 12,964 5,333,198 715,149,750
Net Income/Employee (TTM) -1,081,385 -5,689,194 82,590,366
Receivable Turnover (TTM) -- 4.22 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.01 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -95.58 0.77 9.73
Return on Assets - 5 Yr. Avg. -- 2.50 10.90
Return on Investment (TTM) -104.60 1.54 12.72
Return on Investment - 5 Yr. Avg. -- 1.99 14.02
Return on Equity (TTM) -104.60 0.30 14.84
Return on Equity - 5 Yr. Avg. -- -2.37 15.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -203.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cue Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.90%
# of Holders: 63
Total Shares Held: 4,207,182
3 Mo. Net Change: 1,317,102
# New Positions: 17
# Closed Positions: 3
# Increased Positions: 48
# Reduced Positions: 10
# Net Buyers: 38
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.